Nancy Wysenski
CIK 1294596 · EVP, Chief Commercial Officer · last filed 2026-05-27
Nancy Wysenski is an EVP, Chief Commercial Officer who has filed 83 SEC Form 4 insider transactions across 9 companies since 2007. The most recent filing, for CYTK, was dated May 27, 2026. Across all open-market trades the lifetime net is −$34.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $18.2M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$18.19M
9
83
-$34.94M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CYTK | Director | 33,917 | $70.15 | $2.38M | $0 | 29 | 2026-05-27 |
| ALKS | Director | 33,028 | $44.28 | $1.46M | -$1.01M | 19 | 2023-07-10 |
| Provention Bio, Inc. (PRVB) Delisted | Director | — | $24.98 | — | $0 | 5 | 2023-04-27 |
| Dova Pharmaceuticals Inc. (DOVA) Delisted | Director | 0 | — | — | $0 | 4 | 2019-11-12 |
| TETRAPHASE PHARMACEUTICALS INC (TTPH) Delisted | Director | — | — | — | $0 | 6 | 2019-06-11 |
| INO | Director | 5,000 | $1.10 | $5.5K | $0 | 4 | 2016-05-16 |
| VRTX | EVP, Chief Commercial Officer | 32,232 | $444.93 | $14.34M | -$33.93M | 11 | 2012-06-01 |
| ENDO HEALTH SOLUTIONS INC. (ENDP) Delisted | Chief Operating Officer | 13,054 | $0.29 | $3.8K | $0 | 3 | 2009-03-02 |
| NORTH AMERICAN SCIENTIFIC INC (NASI) Delisted | Director | — | — | — | $0 | 2 | 2008-05-01 |
Recent Filings
83 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-27 | CYTK | Grant (A) | +2,851 | $0 | EDGAR |
| 2026-04-15 | CYTK | Grant (A) | +95 | $6.2K | EDGAR |
| 2026-01-16 | CYTK | Grant (A) | +98 | $6.2K | EDGAR |
| 2025-10-16 | CYTK | Grant (A) | +99 | $6.2K | EDGAR |
| 2025-07-16 | CYTK | Grant (A) | +164 | $6.2K | EDGAR |
| 2025-05-14 | CYTK | Grant (A) | +7,333 | $0 | EDGAR |
| 2025-04-16 | CYTK | Grant (A) | +162 | $6.2K | EDGAR |
| 2025-01-06 | CYTK | Grant (A) | +127 | $6.2K | EDGAR |
| 2024-10-03 | CYTK | Grant (A) | +118 | $6.2K | EDGAR |
| 2024-07-03 | CYTK | Grant (A) | +114 | $0 | EDGAR |